Indivior plans shifting primary listing to U.S.

In this article:

Feb 22 (Reuters) - Drugmaker Indivior Plc said on Thursday it has started consulting shareholders on potentially shifting its primary listing to the U.S. and maintain a second listing in the UK. (Reporting by Aby Jose Koilparambil in Bengaluru; Editing by Savio D'Souza)

Advertisement